Codexis Inc (CDXS) 2.43 $CDXS
Global Synthetic Biology Market Forecasts and Opportunities, 2020
M2 - Tue Sep 02, 5:25AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jnnz65/global_synthetic) has announced the addition of the "Global Synthetic Biology Market (Products, Technologies, Applications and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020" report to their offering. Global synthetic biology market was valued at $3.0 billion in 2013 and it is estimated to reach $38.7 billion by 2020, growing at a CAGR of 44.2% during the forecast period. Synthetic biology is a novel field that finds its origin at the intersection of biology and engineering. It involves designing and construction of biological systems or devices that can be applied in varied domains to get specified results. It's a multidisciplinary effort made by scientists to understand the functioning of biological organisms, cells & genes and implementation of artificial genetic processes to give specific characteristics to an organism. It can even be used to develop a completely new biological system. Assistance from government and private organizations, rising number of entities conducting research and declining cost of DNA sequencing and synthesizing are key driving factors of the market. Governments are providing funds to research organizations, assisting them to find novel applications of synthetic biology. Bio-safety & bio-security issues, ethical issues and regulations are key retraining factors of the market. The fact that synthetic biology can be misused has raised concerns all around the world. Further, there are possibilities of accidental release of pathogens or genetically modified organisms into free atmosphere. Report Scope Key Deliverables Market by Products - Enabling Products - DNA Synthesis - Oligonucleotide Synthesis - Enabled Products - Pharmaceuticals - Chemicals - Biofuels - Agriculture - Core Products - Synthetic DNA - Synthetic Genes - Synthetic Cells - XNA - Chassis Organisms Market by Technology - Enabling Technology - Genome Engineering - Microfluidics technologies - DNA synthesis & sequencing technologies - Bioinformatics technologies - Biological components and integrated systems technologies - Enabled Technology - Pathway engineering - Synthetic microbial consortia - Biofuels technologies Market by Application Research & Development - Chemicals - Agriculture - Pharmaceuticals & Diagnostics - Biofuels - Others (Environment, Biotechnology & Biomaterials, etc.) Companies Mentioned - Algenol Biofuels - BASF - BioAmber - BioSearch Technologies - Butamax Advanced Biofuels - Codexis Inc. - Dupont - GEN9 Inc. - Gensript Corporation - Origene Technologies - Synthetic Genomics For more information visit http://www.researchandmarkets.com/research/jn..._synthetic
Codexis Reports Financial Results for the Second Quarter of 2014
GlobeNewswire - Wed Aug 06, 3:02PM CDT
Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced its financial results for the second quarter ended June 30, 2014.
5 Stocks Ready for Breakouts
at The Street - Mon Aug 04, 9:14AM CDT
These stocks are within range of triggering breakout trades.
Codexis to Announce Second Quarter 2014 Financial Results on August 6, 2014
GlobeNewswire - Thu Jul 31, 3:43PM CDT
Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced it will host a live conference call and audio webcast on Wednesday, August 6, 2014 at 4:30 p.m. Eastern Time to discuss its second quarter 2014 financial results. The call and webcast will follow the release of second quarter financial results after market close. A recorded version of the call will be available approximately one hour after the call on the Investors section of the company's website, www.codexis.com, and will be archived for up to 30 days.
Gordon Sangster to Join Codexis as Senior Vice President & Chief Financial Officer
GlobeNewswire - Mon Jul 28, 3:01PM CDT
Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced that Gordon Sangster has agreed to join Codexis as Senior Vice President & Chief Financial Officer. Gordon, who will start on August 18, 2014, will manage all aspects of Codexis' financial and accounting functions and will report to John Nicols, President & Chief Executive Officer.
Biotechnology Sector Trends Higher with Breakthrough Clinical Trials, Collaborations & License Agreements
PR Newswire - Wed Jul 16, 7:15AM CDT
Biotechnology Companies strive to improve cancer treatment and develop innovative therapies as biotech sector sees growth as well as registered success: GenSpera, Inc. (OTC: GNSZ), Codexis, Inc. (NASDAQ: CDXS), Eli Lilly and Company (NYSE: LLY), Pfizer Inc. (NYSE: PFE), Johnson & Johnson (NYSE: JNJ) and Seattle Genetics (NASDAQ: SGEN).
Why Codexis (CDXS) Stock Hit a One-Year High Today
at The Street - Tue Jul 15, 1:11PM CDT
Codexis (CDXS) soared to a 52-week high of $2.65 on Tuesday after the biocatalyst developer announced a technology licensing agreement with GlaxoSmithKline (GSK).
Codexis licenses its protein engineering platform technology to GlaxoSmithKline
M2 - Tue Jul 15, 8:24AM CDT
Biocatalysts company Codexis (NasdaqGS:CDXS) disclosed on Monday the execution of a platform technology license agreement for its proprietary CodeEvolver protein engineering platform technology with GlaxoSmithKline (GSK).
Codexis Announces Technology Collaboration and License Agreement With GSK
GlobeNewswire - Mon Jul 14, 3:01PM CDT
Codexis to Receive Up to $25 Million of Initial Payments, Plus Additional Milestone and Royalty Opportunities
2014 Report on the International Alcohol and Starch/Sugar Enzyme (Carbohydrase, Protease, and Lipase) Market - Forecasts to 2018
PR Newswire Europe - Mon Jun 30, 12:00PM CDT
Research and Markets (http://www.researchandmarkets.com/research/qzldlf/alcohol_and [http://www.researchandmarkets.com/research/qzldlf/alcohol_and]) has announced the addition of the "2014 Report on the International Alcohol and Starch/Sugar Enzyme (Carbohydrase, Protease, and Lipase) Market - Forecasts to 2018" [http://www.researchandmarkets.com/research/qzldlf/alcohol_and] report to their offering.
Global Synthetic Biology Market (Products, Technologies, Applications and Geography) - Forecast to 2020
M2 - Fri Jun 27, 6:56AM CDT
Research and Markets (http://www.researchandmarkets.com/research/khgmv9/global_synthetic) has announced the addition of the "Global Synthetic Biology Market (Products, Technologies, Applications and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020" report to their offering. According to the new report titled "Global Synthetic Biology Market (Products, Technologies, Applications and Geography) - Global Opportunity Analysis and Forecast - 2013 - 2020", the global synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Synthetic biology is at a nascent stage and has recently entered the commercial market. Many technologies that utilize synthetic biology are yet to be commercialized, and are waiting for approvals from the respective regional regulatory bodies. However, this market is expected to witness adoption in varied domains, with chemicals, pharmaceuticals, energy and agriculture, as some major application markets. Key factors fueling the growth of this market include assistance from government and private organizations, rising number of entities conducting research and declining cost of DNA sequencing and synthesizing. Key Topics Covered: CHAPTER 1 INTRODUCTION CHAPTER 2 EXECUTIVE SUMMARY CHAPTER 3 MARKET OVERVIEW CHAPTER 4 GLOBAL SYNTHETIC BIOLOGY MARKET BY PRODUCT CHAPTER 5 GLOBAL SYNTHETIC BIOLOGY MARKET BY TECHNOLOGIES CHAPTER 6 GLOBAL SYNTHETIC BIOLOGY MARKET BY APPLICATION CHAPTER 7 SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY CHAPTER 8 COMPANY PROFILES Companies Mentioned: - Algenol Biofuels - BASF - BioAmber - BioSearch Technologies - Butamax Advanced Biofuels - Codexis Inc. - Dupont - GEN9 Inc. - Gensript Corporation - Origene Technologies - Synthetic Genomics For more information visit http://www.researchandmarkets.com/research/kh..._synthetic
Global Alcohol and Starch/Sugar Enzyme (Carbohydrase, Protease, and Lipase) Report - Forecasts & Opportunities to 2018
M2 - Wed Apr 02, 6:51AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2qtvfx/alcohol_and) has announced the addition of the "Alcohol and Starch/Sugar Enzyme Market by Type, Application & Geography - Global Trends & Forecasts to 2018" report to their offering. This research report provides a comprehensive analysis of the global alcohol and starch/sugar enzymes market, which witnesses faster growth on account of its diverse applications in the industrial and specialty sector. Massive investments in research and development for new products drive the demand for alcohol and starch/sugar enzymes, tremendously. This report also describes the key players in alcohol and starch/sugar enzymes business across the globe. The regions covered include North America (U.S., Canada, and Mexico), Europe (U.K., Germany, France, Italy, and Spain), Asia-Pacific, and Rest of the World (South Africa and Brazil). The report is focused on the detailed study of the types and applications of alcohol and starch/sugar enzymes in different geographical regions, with a thorough analysis of the market players in the alcohol and starch/sugar enzymes business. Novozymes (Denmark), DuPont (U.S.), Roquette Freres (France), Dyadic International Inc. (U.S.), Amano Enzymes Inc. (Japan), Advanced Enzymes Technologies Ltd. (India), ABF Plc. (U.K.), The Soufflet group (France), Codexis Inc. (U.S.), Lesaffre (France), etc., are the key players in the alcohol and starch/sugar enzymes industry.The recent development strategies of these key playershave been studied. Asia-Pacific is projected to be the fastest-growing market for alcohol and starch/sugar enzymes. The U.S. wine market is the world's second largest market, which is estimated toincrease the demand of alcohol enzymes to process wine. The U.S. is the most important contributor for the growth of starch/sugar enzymes market in North America. Extensive investments are made in research and development to develop advanced products so that the maximum market share can be occupied by introducing new and improved products to suffice the customers' demands. The market for alcohol and starch/sugar enzymes is anticipated to generate significant amounts of revenues considering the rise indemand for food and beverages, biofuels, cleaning agents, pharmaceuticals, biocatalysts, along with research & biotechnology products. The Asia-Pacific region is witnessing a steady demand for alcohol and starch/sugar enzymes due to the expansion strategies of global industrial and pharmaceutical companies situated in this region. Rapid industrialization and development in infrastructure as well as co-operation from local governments has driven the market for alcohol and starch/sugar enzymes in the Asia-Pacific region. The U.S. is a key market in the North American region for alcohol and starch/sugar enzymes due to extensive pharmaceuticals production and research & biotechnology applications. The growth strategies of market players have been identified and analyzed. The manufacturers are exploring the Asia-Pacific and Latin American markets for potential customers. Scope of the Report Type - Carbohydrases - Protease - Lipases - Others Application - Alcohol enzymes - - Industrial - - Specialty - Starch/sugar enzymes - - Industrial - - Specialty Key Topics Covered: - Introduction - Executive Summary - Market Overview - Premium Insights - Alcohol & Starch/Sugar Enzymes Market, By Type - Alocohol & Starch/Sugar Enzymes Market, By Application - Alcohol & Starch/Sugar Enzymes Market, By Geography - Competitive Landscape - Company Profiles - ABF Plc - Advanced Enzyme Technology Ltd. - Amano Enzyme Inc. - Codexis Inc. - Dupont De Nemours & Co. (Dupont) Msds - Dyadic International Inc. - Lesaffre - Novozymes A/S - Roquette Freres - The Soufflet Group For more information visit http://www.researchandmarkets.com/research/2q...lcohol_and
Specialty Enzymes Market by Source, Type, Application & Geography - Global Trends & Forecasts to 2018
M2 - Thu Mar 20, 3:55AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cpjrtc/specialty_enzymes) has announced the addition of the "Specialty Enzymes Market by Source, Type, Application & Geography - Global Trends & Forecasts to 2018" report to their offering. Specialty enzymes are natural proteins produced from micro organisms, plants and animals. An enzyme serves as catalysts for the chemical process that include the production of pharmaceuticals, diagnostics, research & biotechnology, and biocatalytic solutions. Enzymes increase reaction rates by decreasing the amount of energy required to form a complex of reactants that is competent to produce reaction products. Specialty enzymes according to their type are classified as carbohydrases, proteases, polymerases and nucleases, lipases, and others. Specialty enzymes report covers analysis of the market structure by identifying various sub-segments of the global specialty enzymes market, Revenue forecasts of the global specialty enzymes markets and its various sub-markets/micro-markets with respect to four main regions- North America, Europe, Asia-Pacific, and Rest of the World (RoW). Major trends, drivers, and restraints of the global specialty enzymes market are identified and explained in detail. The specialty enzyme markets include pharmaceutical, research and biotechnology, diagnostics and biocatalysts. Pharmaceutical manufacturers are witnessing increased awareness in incorporating biocatalysis into manufacturing processes. Enzymes are particularly useful to generate isomerically pure pharmaceuticals and fine chemicals In spite of numerous advantages of biocatalysis, manufacturers have been slow to adopt industrial-scale enzymatic approaches. Key Topics Covered: Introduction Executive Summary Premium Insights Market Overview Global Specialty Enzymes Market, By Source Specialty Enzyme Market, By Type Specialty Enzyme Market, By Application Specialty Enzymes Market, By Geography Competitive Landscape Company Profiles List of Tables List of Figures Companies Mentioned - Advanced Enzyme Technology Ltd. - Affymetrix Inc. - Amano Enzyme Inc. - Basf - Bbi Enzymes Ltd. - Codexis Inc. - Life Technologies - Nagase & Co. Ltd. - Roche Holding Ag. - Sanofi S.A. For more information visit http://www.researchandmarkets.com/research/cp...ty_enzymes About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Industrial Enzymes Market by Types (Carbohydrase, Protease, Lipase) & Applications (Food & Beverages, Cleaning Agents, Bio-Fuel, Animal Feed) to 2018
M2 - Wed Mar 19, 10:10AM CDT
Research and Markets (http://www.researchandmarkets.com/research/n84g3h/industrial) has announced the addition of the "Industrial Enzymes Market by Types, Applications, & Geography - Global Trends & Forecasts to 2018" report to their offering. The global industrial enzymes market consists of various enzymes, which can be broadly categorized as carbohydrases, proteases, lipases, and others. Carbohydrase is the fastest growing segment of this market in terms of growth rate. Carbohydrases form the major class of enzymes that catalyzes the breakdown of carbohydrates into simple sugar. They also account for the largest market share in the food and beverage, detergent, and textile industry. Other sub-types of types of carbohydrases include amylase, cellulose, lactase, and pectinase. Enzymes are gaining importance in various industrial products and processes due to effective catalytic properties exhibited by them. New developments in biotechnology and protein engineering provide a platform for the development of new enzymes efficiently; hence new enzymes with improved properties are increasingly being used for technical applications as well as in the unexplored field of their usage. One of the important uses of industrial enzymes is in the cleaning agents industry. Proteases, amylases, lipases, and celluloses are used for this purpose. These enzymes render powerful stain removing techniques and other benefits such as fabric care, whiteness, and color fastened fabrics. Enzymes have been extensively used in animal feed additives to provide healthy feed supplements for feed products. The global industrial enzymes market has observed significant developments in from 2012 to 2013. The industry has observed various key players entering into agreements and collaborations to enhance their research capabilities and to further extend their product portfolio. North America was the biggest market for industrial enzymes, followed by Europe due to maximum key players situated in these regions as well as the increasing demand for higher yield enzymes to suffice the growing demand for cleaning agents, biofuels, food and beverages, as well as textiles, paper & pulp processing, etc. The core technology that has helped expand the industrial enzyme industry is genetic engineering. It has paved a way to exploit new types of enzymes and new source organisms, which has in turn helped in cost reduction, development, and production of enzymes. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Executive Summary 5 Premium Insights 6 Global Industrial Enzymes Market, By Type 7 Global Industrial Enzymes, By Application 8 Industrial Enzyme Market, By Geography 9 Competitive Landscape 10 Company Profiles - Abf Plc. - Amano Enzyme Inc. - Basf - Chr. Hansen Holding A/S - Codexis Inc. - Dsm - Dupont De Nemours & Co. (Dupont) Msds. - Dyadic International Inc. - Novozymes A/S - The Soufflet Group For more information visit http://www.researchandmarkets.com/research/n84g3h/industrial
Intrexon Acquires Laboratory Operations from Codexis and Expands Presence to Europe
PR Newswire Europe - Mon Mar 17, 2:01AM CDT
-- Company Increases Bioproduction Capabilities and Capacity
Codexis Sells Its Hungarian Operations to Intrexon Corporation
GlobeNewswire - Thu Mar 13, 3:30PM CDT
Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced the sale of its subsidiary in Hungary to Intrexon Corporation. The transaction closed on March 13, 2014, with a purchase price of $1.5 million. No proprietary Codexis materials or intellectual property were included in the transaction.
Codexis Reports Fourth Quarter and Full Year 2013 Results
GlobeNewswire - Tue Mar 11, 3:04PM CDT
Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced its financial results for the fourth quarter and year ended December 31, 2013.
Dyadic Withdraws Notice Of Breach Letter Relating To Its C1 License Agreement With Codexis
PR Newswire - Mon Mar 10, 3:38PM CDT
Dyadic International, Inc. ("Dyadic"
(OTC Pink: DYAI), a global biotechnology company, announced today that it received notice from Codexis, Inc. that it will no longer be pursuing its advanced biofuels program. This notice is consistent with Codexis' previous public announcement on November 12, 2013 that it was immediately winding down its advanced biofuels program.
Global Synthetic Biology Market Forecasts and Opportunities, 2020
M2 - Tue Sep 02, 5:25AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jnnz65/global_synthetic) has announced the addition of the "Global Synthetic Biology Market (Products, Technologies, Applications and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020" report to their offering. Global synthetic biology market was valued at $3.0 billion in 2013 and it is estimated to reach $38.7 billion by 2020, growing at a CAGR of 44.2% during the forecast period. Synthetic biology is a novel field that finds its origin at the intersection of biology and engineering. It involves designing and construction of biological systems or devices that can be applied in varied domains to get specified results. It's a multidisciplinary effort made by scientists to understand the functioning of biological organisms, cells & genes and implementation of artificial genetic processes to give specific characteristics to an organism. It can even be used to develop a completely new biological system. Assistance from government and private organizations, rising number of entities conducting research and declining cost of DNA sequencing and synthesizing are key driving factors of the market. Governments are providing funds to research organizations, assisting them to find novel applications of synthetic biology. Bio-safety & bio-security issues, ethical issues and regulations are key retraining factors of the market. The fact that synthetic biology can be misused has raised concerns all around the world. Further, there are possibilities of accidental release of pathogens or genetically modified organisms into free atmosphere. Report Scope Key Deliverables Market by Products - Enabling Products - DNA Synthesis - Oligonucleotide Synthesis - Enabled Products - Pharmaceuticals - Chemicals - Biofuels - Agriculture - Core Products - Synthetic DNA - Synthetic Genes - Synthetic Cells - XNA - Chassis Organisms Market by Technology - Enabling Technology - Genome Engineering - Microfluidics technologies - DNA synthesis & sequencing technologies - Bioinformatics technologies - Biological components and integrated systems technologies - Enabled Technology - Pathway engineering - Synthetic microbial consortia - Biofuels technologies Market by Application Research & Development - Chemicals - Agriculture - Pharmaceuticals & Diagnostics - Biofuels - Others (Environment, Biotechnology & Biomaterials, etc.) Companies Mentioned - Algenol Biofuels - BASF - BioAmber - BioSearch Technologies - Butamax Advanced Biofuels - Codexis Inc. - Dupont - GEN9 Inc. - Gensript Corporation - Origene Technologies - Synthetic Genomics For more information visit http://www.researchandmarkets.com/research/jn..._synthetic
Codexis Reports Financial Results for the Second Quarter of 2014
GlobeNewswire - Wed Aug 06, 3:02PM CDT
Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced its financial results for the second quarter ended June 30, 2014.
5 Stocks Ready for Breakouts
at The Street - Mon Aug 04, 9:14AM CDT
These stocks are within range of triggering breakout trades.
Codexis to Announce Second Quarter 2014 Financial Results on August 6, 2014
GlobeNewswire - Thu Jul 31, 3:43PM CDT
Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced it will host a live conference call and audio webcast on Wednesday, August 6, 2014 at 4:30 p.m. Eastern Time to discuss its second quarter 2014 financial results. The call and webcast will follow the release of second quarter financial results after market close. A recorded version of the call will be available approximately one hour after the call on the Investors section of the company's website, www.codexis.com, and will be archived for up to 30 days.
Gordon Sangster to Join Codexis as Senior Vice President & Chief Financial Officer
GlobeNewswire - Mon Jul 28, 3:01PM CDT
Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced that Gordon Sangster has agreed to join Codexis as Senior Vice President & Chief Financial Officer. Gordon, who will start on August 18, 2014, will manage all aspects of Codexis' financial and accounting functions and will report to John Nicols, President & Chief Executive Officer.
Biotechnology Sector Trends Higher with Breakthrough Clinical Trials, Collaborations & License Agreements
PR Newswire - Wed Jul 16, 7:15AM CDT
Biotechnology Companies strive to improve cancer treatment and develop innovative therapies as biotech sector sees growth as well as registered success: GenSpera, Inc. (OTC: GNSZ), Codexis, Inc. (NASDAQ: CDXS), Eli Lilly and Company (NYSE: LLY), Pfizer Inc. (NYSE: PFE), Johnson & Johnson (NYSE: JNJ) and Seattle Genetics (NASDAQ: SGEN).
Why Codexis (CDXS) Stock Hit a One-Year High Today
at The Street - Tue Jul 15, 1:11PM CDT
Codexis (CDXS) soared to a 52-week high of $2.65 on Tuesday after the biocatalyst developer announced a technology licensing agreement with GlaxoSmithKline (GSK).
Codexis licenses its protein engineering platform technology to GlaxoSmithKline
M2 - Tue Jul 15, 8:24AM CDT
Biocatalysts company Codexis (NasdaqGS:CDXS) disclosed on Monday the execution of a platform technology license agreement for its proprietary CodeEvolver protein engineering platform technology with GlaxoSmithKline (GSK).
Codexis Announces Technology Collaboration and License Agreement With GSK
GlobeNewswire - Mon Jul 14, 3:01PM CDT
Codexis to Receive Up to $25 Million of Initial Payments, Plus Additional Milestone and Royalty Opportunities
2014 Report on the International Alcohol and Starch/Sugar Enzyme (Carbohydrase, Protease, and Lipase) Market - Forecasts to 2018
PR Newswire Europe - Mon Jun 30, 12:00PM CDT
Research and Markets (http://www.researchandmarkets.com/research/qzldlf/alcohol_and [http://www.researchandmarkets.com/research/qzldlf/alcohol_and]) has announced the addition of the "2014 Report on the International Alcohol and Starch/Sugar Enzyme (Carbohydrase, Protease, and Lipase) Market - Forecasts to 2018" [http://www.researchandmarkets.com/research/qzldlf/alcohol_and] report to their offering.
Global Synthetic Biology Market (Products, Technologies, Applications and Geography) - Forecast to 2020
M2 - Fri Jun 27, 6:56AM CDT
Research and Markets (http://www.researchandmarkets.com/research/khgmv9/global_synthetic) has announced the addition of the "Global Synthetic Biology Market (Products, Technologies, Applications and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020" report to their offering. According to the new report titled "Global Synthetic Biology Market (Products, Technologies, Applications and Geography) - Global Opportunity Analysis and Forecast - 2013 - 2020", the global synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Synthetic biology is at a nascent stage and has recently entered the commercial market. Many technologies that utilize synthetic biology are yet to be commercialized, and are waiting for approvals from the respective regional regulatory bodies. However, this market is expected to witness adoption in varied domains, with chemicals, pharmaceuticals, energy and agriculture, as some major application markets. Key factors fueling the growth of this market include assistance from government and private organizations, rising number of entities conducting research and declining cost of DNA sequencing and synthesizing. Key Topics Covered: CHAPTER 1 INTRODUCTION CHAPTER 2 EXECUTIVE SUMMARY CHAPTER 3 MARKET OVERVIEW CHAPTER 4 GLOBAL SYNTHETIC BIOLOGY MARKET BY PRODUCT CHAPTER 5 GLOBAL SYNTHETIC BIOLOGY MARKET BY TECHNOLOGIES CHAPTER 6 GLOBAL SYNTHETIC BIOLOGY MARKET BY APPLICATION CHAPTER 7 SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY CHAPTER 8 COMPANY PROFILES Companies Mentioned: - Algenol Biofuels - BASF - BioAmber - BioSearch Technologies - Butamax Advanced Biofuels - Codexis Inc. - Dupont - GEN9 Inc. - Gensript Corporation - Origene Technologies - Synthetic Genomics For more information visit http://www.researchandmarkets.com/research/kh..._synthetic
Global Alcohol and Starch/Sugar Enzyme (Carbohydrase, Protease, and Lipase) Report - Forecasts & Opportunities to 2018
M2 - Wed Apr 02, 6:51AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2qtvfx/alcohol_and) has announced the addition of the "Alcohol and Starch/Sugar Enzyme Market by Type, Application & Geography - Global Trends & Forecasts to 2018" report to their offering. This research report provides a comprehensive analysis of the global alcohol and starch/sugar enzymes market, which witnesses faster growth on account of its diverse applications in the industrial and specialty sector. Massive investments in research and development for new products drive the demand for alcohol and starch/sugar enzymes, tremendously. This report also describes the key players in alcohol and starch/sugar enzymes business across the globe. The regions covered include North America (U.S., Canada, and Mexico), Europe (U.K., Germany, France, Italy, and Spain), Asia-Pacific, and Rest of the World (South Africa and Brazil). The report is focused on the detailed study of the types and applications of alcohol and starch/sugar enzymes in different geographical regions, with a thorough analysis of the market players in the alcohol and starch/sugar enzymes business. Novozymes (Denmark), DuPont (U.S.), Roquette Freres (France), Dyadic International Inc. (U.S.), Amano Enzymes Inc. (Japan), Advanced Enzymes Technologies Ltd. (India), ABF Plc. (U.K.), The Soufflet group (France), Codexis Inc. (U.S.), Lesaffre (France), etc., are the key players in the alcohol and starch/sugar enzymes industry.The recent development strategies of these key playershave been studied. Asia-Pacific is projected to be the fastest-growing market for alcohol and starch/sugar enzymes. The U.S. wine market is the world's second largest market, which is estimated toincrease the demand of alcohol enzymes to process wine. The U.S. is the most important contributor for the growth of starch/sugar enzymes market in North America. Extensive investments are made in research and development to develop advanced products so that the maximum market share can be occupied by introducing new and improved products to suffice the customers' demands. The market for alcohol and starch/sugar enzymes is anticipated to generate significant amounts of revenues considering the rise indemand for food and beverages, biofuels, cleaning agents, pharmaceuticals, biocatalysts, along with research & biotechnology products. The Asia-Pacific region is witnessing a steady demand for alcohol and starch/sugar enzymes due to the expansion strategies of global industrial and pharmaceutical companies situated in this region. Rapid industrialization and development in infrastructure as well as co-operation from local governments has driven the market for alcohol and starch/sugar enzymes in the Asia-Pacific region. The U.S. is a key market in the North American region for alcohol and starch/sugar enzymes due to extensive pharmaceuticals production and research & biotechnology applications. The growth strategies of market players have been identified and analyzed. The manufacturers are exploring the Asia-Pacific and Latin American markets for potential customers. Scope of the Report Type - Carbohydrases - Protease - Lipases - Others Application - Alcohol enzymes - - Industrial - - Specialty - Starch/sugar enzymes - - Industrial - - Specialty Key Topics Covered: - Introduction - Executive Summary - Market Overview - Premium Insights - Alcohol & Starch/Sugar Enzymes Market, By Type - Alocohol & Starch/Sugar Enzymes Market, By Application - Alcohol & Starch/Sugar Enzymes Market, By Geography - Competitive Landscape - Company Profiles - ABF Plc - Advanced Enzyme Technology Ltd. - Amano Enzyme Inc. - Codexis Inc. - Dupont De Nemours & Co. (Dupont) Msds - Dyadic International Inc. - Lesaffre - Novozymes A/S - Roquette Freres - The Soufflet Group For more information visit http://www.researchandmarkets.com/research/2q...lcohol_and
Specialty Enzymes Market by Source, Type, Application & Geography - Global Trends & Forecasts to 2018
M2 - Thu Mar 20, 3:55AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cpjrtc/specialty_enzymes) has announced the addition of the "Specialty Enzymes Market by Source, Type, Application & Geography - Global Trends & Forecasts to 2018" report to their offering. Specialty enzymes are natural proteins produced from micro organisms, plants and animals. An enzyme serves as catalysts for the chemical process that include the production of pharmaceuticals, diagnostics, research & biotechnology, and biocatalytic solutions. Enzymes increase reaction rates by decreasing the amount of energy required to form a complex of reactants that is competent to produce reaction products. Specialty enzymes according to their type are classified as carbohydrases, proteases, polymerases and nucleases, lipases, and others. Specialty enzymes report covers analysis of the market structure by identifying various sub-segments of the global specialty enzymes market, Revenue forecasts of the global specialty enzymes markets and its various sub-markets/micro-markets with respect to four main regions- North America, Europe, Asia-Pacific, and Rest of the World (RoW). Major trends, drivers, and restraints of the global specialty enzymes market are identified and explained in detail. The specialty enzyme markets include pharmaceutical, research and biotechnology, diagnostics and biocatalysts. Pharmaceutical manufacturers are witnessing increased awareness in incorporating biocatalysis into manufacturing processes. Enzymes are particularly useful to generate isomerically pure pharmaceuticals and fine chemicals In spite of numerous advantages of biocatalysis, manufacturers have been slow to adopt industrial-scale enzymatic approaches. Key Topics Covered: Introduction Executive Summary Premium Insights Market Overview Global Specialty Enzymes Market, By Source Specialty Enzyme Market, By Type Specialty Enzyme Market, By Application Specialty Enzymes Market, By Geography Competitive Landscape Company Profiles List of Tables List of Figures Companies Mentioned - Advanced Enzyme Technology Ltd. - Affymetrix Inc. - Amano Enzyme Inc. - Basf - Bbi Enzymes Ltd. - Codexis Inc. - Life Technologies - Nagase & Co. Ltd. - Roche Holding Ag. - Sanofi S.A. For more information visit http://www.researchandmarkets.com/research/cp...ty_enzymes About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Industrial Enzymes Market by Types (Carbohydrase, Protease, Lipase) & Applications (Food & Beverages, Cleaning Agents, Bio-Fuel, Animal Feed) to 2018
M2 - Wed Mar 19, 10:10AM CDT
Research and Markets (http://www.researchandmarkets.com/research/n84g3h/industrial) has announced the addition of the "Industrial Enzymes Market by Types, Applications, & Geography - Global Trends & Forecasts to 2018" report to their offering. The global industrial enzymes market consists of various enzymes, which can be broadly categorized as carbohydrases, proteases, lipases, and others. Carbohydrase is the fastest growing segment of this market in terms of growth rate. Carbohydrases form the major class of enzymes that catalyzes the breakdown of carbohydrates into simple sugar. They also account for the largest market share in the food and beverage, detergent, and textile industry. Other sub-types of types of carbohydrases include amylase, cellulose, lactase, and pectinase. Enzymes are gaining importance in various industrial products and processes due to effective catalytic properties exhibited by them. New developments in biotechnology and protein engineering provide a platform for the development of new enzymes efficiently; hence new enzymes with improved properties are increasingly being used for technical applications as well as in the unexplored field of their usage. One of the important uses of industrial enzymes is in the cleaning agents industry. Proteases, amylases, lipases, and celluloses are used for this purpose. These enzymes render powerful stain removing techniques and other benefits such as fabric care, whiteness, and color fastened fabrics. Enzymes have been extensively used in animal feed additives to provide healthy feed supplements for feed products. The global industrial enzymes market has observed significant developments in from 2012 to 2013. The industry has observed various key players entering into agreements and collaborations to enhance their research capabilities and to further extend their product portfolio. North America was the biggest market for industrial enzymes, followed by Europe due to maximum key players situated in these regions as well as the increasing demand for higher yield enzymes to suffice the growing demand for cleaning agents, biofuels, food and beverages, as well as textiles, paper & pulp processing, etc. The core technology that has helped expand the industrial enzyme industry is genetic engineering. It has paved a way to exploit new types of enzymes and new source organisms, which has in turn helped in cost reduction, development, and production of enzymes. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Executive Summary 5 Premium Insights 6 Global Industrial Enzymes Market, By Type 7 Global Industrial Enzymes, By Application 8 Industrial Enzyme Market, By Geography 9 Competitive Landscape 10 Company Profiles - Abf Plc. - Amano Enzyme Inc. - Basf - Chr. Hansen Holding A/S - Codexis Inc. - Dsm - Dupont De Nemours & Co. (Dupont) Msds. - Dyadic International Inc. - Novozymes A/S - The Soufflet Group For more information visit http://www.researchandmarkets.com/research/n84g3h/industrial
Intrexon Acquires Laboratory Operations from Codexis and Expands Presence to Europe
PR Newswire Europe - Mon Mar 17, 2:01AM CDT
-- Company Increases Bioproduction Capabilities and Capacity
Codexis Sells Its Hungarian Operations to Intrexon Corporation
GlobeNewswire - Thu Mar 13, 3:30PM CDT
Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced the sale of its subsidiary in Hungary to Intrexon Corporation. The transaction closed on March 13, 2014, with a purchase price of $1.5 million. No proprietary Codexis materials or intellectual property were included in the transaction.
Codexis Reports Fourth Quarter and Full Year 2013 Results
GlobeNewswire - Tue Mar 11, 3:04PM CDT
Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced its financial results for the fourth quarter and year ended December 31, 2013.
Dyadic Withdraws Notice Of Breach Letter Relating To Its C1 License Agreement With Codexis
PR Newswire - Mon Mar 10, 3:38PM CDT
Dyadic International, Inc. ("Dyadic"
(OTC Pink: DYAI), a global biotechnology company, announced today that it received notice from Codexis, Inc. that it will no longer be pursuing its advanced biofuels program. This notice is consistent with Codexis' previous public announcement on November 12, 2013 that it was immediately winding down its advanced biofuels program. 
